Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 66.65 INR
Change Today 0.00 / 0.00%
Volume 0.0
WANB On Other Exchanges
Natl India
As of 7:06 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

wanbury ltd (WANB) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/22/15 - 83.20
52 Week Low
02/11/15 - 24.60
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for WANBURY LTD (WANB)

Related News

No related news articles were found.

wanbury ltd (WANB) Related Businessweek News

No Related Businessweek News Found

wanbury ltd (WANB) Details

Wanbury Limited manufactures and sells active pharmaceutical ingredients (API) in India and internationally. Its principal API product therapeutic areas include anti diabetic, anti analgesic, anti depressant, anti histaminic, anti inflammatory, anti arthritis, anti thrombotic, anti epileptic, and anti hypertensive. The company also manufactures formulations for gynecology, orthopedics, heamatinics, neutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, and general practitioner. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Founded in 1988

wanbury ltd (WANB) Top Compensated Officers

Vice Chairman, Chairman of Day-To-Day Affairs...
Total Annual Compensation: 2.8M
Compensation as of Fiscal Year 2014.

wanbury ltd (WANB) Key Developments

Wanbury Ltd. Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Wanbury Ltd. reported unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported net sales/income from operations of INR 1,189.781 million against INR 1,151.160 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 126.020 million against INR 105.223 million a year ago. Profit from ordinary activities before tax was INR 44.501 million against INR 18.688 million a year ago. Net profit for the period was INR 44.501 million or INR 2.23 per basic and diluted share against INR 12.825 million or INR 0.71 per basic and diluted share for the same period a year ago.

Wanbury Ltd. Appoints Anita Belani as an Additional Independent Woman Director

Wanbury Ltd. has announced that the Board of Directors of the Company at its meeting held on August 13, 2015, has approved the appointment of Ms. Anita Belani as an Additional Independent Woman Director.

Wanbury Ltd., Board Meeting, Aug 13, 2015

Wanbury Ltd., Board Meeting, Aug 13, 2015. Agenda: To consider and take on record the unaudited financial results for the first quarter ended on June 30, 2015; to approve appointment of Ms. Anita Belani as an Additional Independent Woman Director; and to approve Code of Conduct for Prohibition of Insider Trading and Code for practices and procedure for Fair Disclosure of Unpublished Price Sensitive Information.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WANB:IN 66.65 INR 0.00

WANB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for WANB.
View Industry Companies

Industry Analysis


Industry Average

Valuation WANB Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WANBURY LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at